DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.

Vol. 29, Issue 4, Part 2, 529-534, April 2001


Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans

Nigel J. Gooderham, Stephen Murray, Anthony M. Lynch, Masoud Yadollahi-Farsani, Kaicun Zhao, Alan R. Boobis, and Donald S. Davies

Molecular Toxicology and Clinical Pharmacology, Imperial College School of Medicine, London, United Kingdom


    Abstract
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

The cooking of meat has been found to generate compounds that possess extreme mutagenicity when examined in short term tests. This observation led to the isolation and identification of a family of mutagenic chemicals, all of which are heterocyclic amines. These amines are potent bacterial and eukaryotic cell mutagens, and all of those tested have been found to induce tumors in laboratory animals. Metabolic activation of the heterocyclic amines predominantly involves CYP1-mediated N-hydroxylation and then O-esterification by phase II enzymes. In contrast, carbon oxidation, glucuronidation, and sulfation reactions at sites other than the hydroxylamine yield detoxication metabolites. In humans, the activities of these pathways are known to vary between individuals and are likely to influence susceptibility to the genetic toxicity of the heterocyclic amines. Clearly, accurate determination of human exposure to the heterocyclic amines and identification of the key enzyme systems involved and their regulation will be required for rational assessment of the risk and will help devise strategies to reduce such risk.


    Introduction
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

Epidemiological studies show that the incidence of human cancer is associated with lifestyle, occupation, iatrogenic, and cryptogenic factors (Williams, 1985). By far the most significant of these is lifestyle, particularly diet and tobacco use, which together may account for ~70% of all human cancer (Doll and Peto, 1981). Among dietary factors, high fat intake, low fiber intake, and the consumption of well cooked meat seem to predispose individuals to cancer of the colon, breast, pancreas, prostate, and the endometrium. The discovery that cooked food can be mutagenic (Commoner et al., 1978) led to efforts to isolate the mutagenic products. Groups in Japan and America showed that the cooking of food generates many compounds that are mutagenic in short-term bacterial assays including polycyclic aromatic hydrocarbons, nitrosamines, and a family of compounds that were all heterocyclic amines (HAs1) (Sugimura and Sato, 1983; Felton et al., 1986). While polycyclic aromatic hydrocarbons were shown to be the major mutagens on a mass basis, the HAs were found to be by far the more potent mutagens. These latter compounds include imidazoquinoxalines, imidazoquinolines, and imidazopyridines (see Fig. 1) and are found when food, particularly red meat, is cooked under normal household conditions; they are not present in uncooked food.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Cooked food-derived mutagenic heterocyclic amines.



    Human Exposure to the Heterocyclic Amines
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

Formation of the HAs has been investigated in model systems, and a requirement for sugars, amino acids, and creatinine (or creatine) has been established (Jagerstad et al., 1991; Skog et al., 1992). These naturally occurring compounds are all present in red meat and can react together during cooking in Maillard reactions, through which food acquires its characteristic flavors, odors, and appearance. By-products of this chemistry include the HAs (Jagerstad et al., 1983). Three of these cooked food-derived HAs, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), are found more frequently than the others; together they account for the majority of the genotoxic potential of fried beef (Felton et al., 1986; Murray et al., 1988; Murray et al., 1993). These three compounds have been detected in beef, lamb, pork, chicken, and fish, especially when chargrilled, fried, or roasted. HAs are present in microgram per gram quantities in cooked meat; nevertheless, human exposure to the HAs, although low, is chronic since meat is consumed daily over a lifetime. Thus, depending upon dietary preferences, an individual's daily exposure to heterocyclic amines is likely to range from microgram quantities to essentially zero in the case of vegetarians. Significantly, the incidence of cancer is approximately 60% lower in vegetarians than in nonvegetarians (Thorogood et al., 1994).

In studies of the fate of administered HAs, it was found that irrespective of the route of administration, oral, intraperitoneal, or intravenous, similar amounts of administered HA radiolabel were excreted in the urine and the feces (Gooderham et al., 1987). This and the fact that most of the radioactivity was eliminated in the first 24 h indicated that the HAs were rapidly and extensively absorbed (Gooderham et al., 1987, 1991). Analysis of the excreted material showed that the majority of an administered dose of heterocyclic amine was biotransformed but that a small proportion (2-5%) was excreted in the urine as unchanged parent amine. Subsequently, similar results were obtained in studies of human volunteers fed fried beef meals (Murray et al., 1989; Lynch et al., 1992) (see Fig. 2). In one such study, fried beef containing known quantities of HAs was fed to healthy volunteers on each of four separate occasions, and urinary excretion of unchanged HAs was examined. Irrespective of the dose, about 2% of the ingested MeIQx and between 0.5 to 1% of the PhIP was excreted unchanged in the urine within 24 h of the test meal, the majority being eliminated within 8 h (Murray et al., 1989; Lynch et al., 1992). Although there was up to 5-fold interindividual variation in the excretion of unchanged amine (Fig. 2), within an individual the percentage excreted on different occasions remained remarkably consistent (Lynch et al., 1992). Excretion of unchanged amine in urine is a function of the extent of absorption and clearance due to metabolism. From animal studies, HA absorption seems to be almost complete; thus, variations in urinary excretion should provide a measure of interindividual variability in the metabolism of these compounds.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Urinary excretion of MeIQx and PhIP in volunteers following a cooked beef meal.



    Metabolism of the Heterocyclic Amines
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

The rapid elimination of HA radiolabel and that only a small amount of amine was excreted unchanged in the urine suggested that these compounds are likely to be extensively metabolized (Gooderham et al., 1987, 1991). In vitro studies with MeIQx and PhIP using liver microsomal preparations from rats, mice, and rabbits showed that at least two oxidative metabolites were formed from each compound, a ring-hydroxylated product and the N-hydroxy derivative (Gooderham et al., 1987; Turesky et al., 1988, 1991; Sjodin et al., 1989; Turteltaub et al., 1989; Watkins et al., 1991a,b). In addition, both the parent amines and their primary oxidative metabolites can be further biotransformed to a variety of phase II metabolites including glucuronides (Kaderlik et al., 1994), sulfate esters (Chou et al., 1995), and acetylated products (Lin et al., 1995). As an example, the routes of PhIP metabolism are shown in Fig. 3. Examination of the primary oxidative metabolites in a mutagenicity assay such as the Ames Salmonella typhimurium test showed that the N-hydroxy metabolites of MeIQx and PhIP were direct-acting mutagens, whereas the ring-hydroxylated products were not (Rich et al., 1992; Zhao et al., 1994). Analysis of HA metabolism by human liver microsomal fractions showed N-hydroxylation to be the primary oxidative route of metabolism of these HAs with Km values of 60 and 55 µM for MeIQx and PhIP, respectively, with little if any aromatic hydroxylation (Rich et al., 1992; Zhao et al., 1994). Clearly, there are species differences in the oxidative metabolism of HAs since experimental animals are able to both activate and detoxify these amines, whereas humans convert them predominantly to their reactive genotoxic metabolite.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   The metabolism of PhIP.

Studies using a variety of different approaches have shown that the genotoxic N-hydroxylation pathway of these amines involves primarily members of the CYP1A subfamily (Watanabe et al., 1982; McManus et al., 1989; Turteltaub et al., 1989; Turesky et al., 1991; Watkins et al., 1991a,b; Rich et al., 1992; Zhao et al., 1994). With human liver microsomes, the highly specific and sensitive inhibitor of human CYP1A2, furafylline, inhibited the formation of N-hydroxy MeIQx by >90% and of N-hydroxy PhIP by about 85% (Table 1). These in vitro findings were confirmed in vivo in a double blind, crossover study (Boobis et al., 1994). Six adult male volunteers were asked to refrain from eating meat or meat products for 24 h before a test meal. On the day of the study they ingested placebo or furafylline (125 mg) and 2 h later consumed a fried beef meal containing a known amount of HAs (determined by gas chromatography/mass spectrometry). In the case of MeIQx, subjects on placebo excreted about 2.2% of the ingested dose as unchanged amine in the urine, but after furafylline this increased almost 15-fold (Table 1). In the case of PhIP, the placebo leg subjects excreted about 1.2% of the administered dose as unchanged PhIP in the urine, whereas after furafylline, this increased about 3.5-fold (Table 1). Both the absolute amount of unchanged amine and the time over which it was excreted were increased after furafylline, demonstrating the substantial contribution of CYP1A2 to the metabolism of these amines in humans.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Effect of furafylline on the metabolism of MeIQx and PhIP

There are reports that CYP1A1, CYP1B1, CYP3A4, CYP2C9, and CYP2A3 are all capable of metabolizing HAs to their genotoxic N-hydroxy derivatives (McManus et al., 1989; Yamazaki et al., 1993; Edwards et al., 1994; Crofts et al., 1997; Hellmold et al., 1998). However, all of these P450 isoforms are less active toward HA substrates than CYP1A2. An illustrative comparative study has been reported by Crofts et al. (1998) in which human P450 isoforms were expressed in insect cells and the kinetic constants of PhIP N-hydroxylation determined under comparable conditions (Table 2). CYP1A1 and CYP1A2 had comparable N-hydroxylation activity, while CYP1B1 was much less active. CYP1A1 had the highest 4-hydroxylation activity. Levels of CYP1A2 in human liver can vary considerably (Sesardic et al., 1990); thus, hepatic metabolism of heterocyclic amines such as PhIP will vary within the human population. CYP1A2 expression is almost exclusively hepatic, whereas CYP1A1 and CYP1B1 have been detected in a variety of extrahepatic organs, usually after exposure to inducing agents. Hence, the hepatic oxidative metabolism of the HAs will be CYP1A2-dependent, whereas in extrahepatic tissues metabolism is likely to be supported by CYP1A1 and to a lesser extent by CYP1B1. Again, variations in the expression of these extrahepatic enzymes will contribute to variation in the overall disposition and toxicity of these compounds.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Comparison of human P450 metabolism of PhIP

Vmax units: nmol min-1 nmol P450-1; Km units: µM.

It has recently been shown that human urinary metabolites of the HAs MeIQx and PhIP include glucuronides and sulfate esters (Turesky et al., 1998; Malfatti et al., 1999). Indeed, N-hydroxy-PhIP-N2-glucuronide is thought to be the major urinary metabolite of PhIP accounting for about 50% of the dose (Malfatti et al., 1999). At least five glucuronides of PhIP have been reported, the N2-glucuronide, N2-hydroxy glucuronide, the N3-glucuronide, the N3-hydroxy glucuronide, and the 4'-hydroxy glucuronide. Since the glucuronides can be eliminated via bile, it is possible that intestinal bacterial beta -glucuronidase could hydrolyze these conjugates, thereby liberating the genotoxic N-hydroxylamine. However, whereas N3-glucuronides can be deconjugated by intestinal bacterial beta -glucuronidase, N2-glucuronides are resistant; thus, generation of genotoxic N-hydroxy-PhIP by bacterial beta -glucuronidase is unlikely to occur in the human intestine.

There is evidence from reconstitution and tissue culture studies that N-hydroxy PhIP can also be sulfated (Buonarati et al., 1990; Chou et al., 1995; Lewis et al., 1998). Three of the sulfotransferases (SULTs 1A2, 1A3, and 1E1) have been shown to sulfate heterocyclic amines and their hydroxylamine derivatives (Buonarati et al., 1990; Ozawa et al., 1994; Lewis et al., 1998; Turesky et al., 1998). The latter isoform, SULT1E1, is known to be hormonally regulated and readily inducible by progesterone. This suggests that sulfation activity could vary, for example during the luteal phase of the menstrual cycle when there is a surge in progesterone levels and SULT1E1 activity may be elevated (Lewis et al., 1998). Since the sulfoxy ester of N-hydroxy-PhIP is an unstable product, its detection in biological samples is likely to be very difficult. However, the 4'-PhIP-sulfate ester, a detoxication product, has been detected in humans, thus demonstrating the involvement of sulfotransferase in PhIP metabolism (Malfatti et al., 1999).

N-Hydroxylation of the HAs, the primary metabolic pathway in humans, is also the primary route of HA genotoxicity. For some HAs, the N-hydroxy metabolite reacts poorly with DNA, but it can be converted to highly reactive derivatives by esterification, e.g., to form N-acetoxy, N-sulfonyloxy, N-propyloxy, and N-phosphatyl derivatives (Schut and Snyderwine, 1999). Studies with bacterial strains that are deficient, proficient, and overexpress acetyltransferase enzymes show the importance of this esterification reaction in the metabolic activation of the heterocyclic amines to bacterial mutagens (see Fig. 4). Like the N-hydroxy sulfate esters, the acetyl esters of the N-hydroxy heterocyclic amines are extremely reactive and readily damage DNA.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of acetyltransferase activity on the bacterial mutagenicity of N-hydroxy PhIP.

Acetyltransferase activity is high in S. typhimurium YG1024 strain, lower in TA98, and very low in TA98DNP.



    Genotoxicity
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

Mutation. In Ames S. typhimurium mutagenicity tests, the HAs have been found to be extremely powerful promutagens causing both frameshift and point mutation (Felton and Knize, 1990). The requirement for metabolic activation and substantial species differences in this reaction affects the comparative genotoxicity of these compounds. Whereas the mouse is good at activating PhIP and MeIQx to genotoxic derivatives, other species such as the rat are poor (Davis et al., 1993). However, activation of the HAs to genotoxic derivatives is very efficient in humans due to high hepatic CYP1A2 activity (Edwards et al., 1994). Species differences in the ability to activate HAs are particularly pronounced between humans and cynomolgus monkey, since the liver of the latter is almost devoid of CYP1A2 expression and is consequently very poor at activating HAs to genotoxic derivatives (Edwards et al., 1994).

Chemically induced mutation in bacterial cells is sometimes not manifest in mammalian cell systems. Since the HAs are such powerful bacterial mutagens, it was important to confirm their genotoxicity in eukaryotic cells. A variety of Chinese hamster cells, both DNA repair-proficient and -deficient have been used to study HA-induced mutagenicity (Thompson et al., 1987). Interestingly, PhIP, a weaker bacterial mutagen than MeIQx, is a particularly potent eukaryotic cell mutagen (Thompson et al., 1987; Felton and Knize, 1990). To explore the molecular nature of PhIP-induced mutation, we have used Chinese hamster V79 cells and the hprt gene as a surrogate marker. Since V79 cells have no intrinsic CYP1A2 activity, culture with PhIP failed to increase the mutation frequency above background spontaneous rate. However a V79 cell line variant, engineered to express human CYP1A2 (XEMh1A2 cells) (Wölfel et al., 1992), showed a good PhIP dose-mutation relationship (Yadollahi-Farsani et al., 1995). Upon analysis, a high percentage of these mutants were G to T transversions together with a significant number of -1 G:C base pair deletions (Table 3), in monotonous runs of G. The preponderance of these guanine-based mutations occurred on the nontranscribed strand (Yadollahi-Farsani et al., 1996).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3
PhIP-induced mutation in hamster XEMh1A2 cells (hprt) in vitro, and in MutaMouse (lacZ) in vivo

The molecular nature of PhIP-induced mutation has also been examined in an in vivo transgenic model, MutaMouse, in which 80 copies of the lacZ bacterial transgene gene are present in every cell (Lynch et al., 1996). The MutaMouse mice were administered oral PhIP (20 mg/kg per day) for 4 days and then examined for mutation in the intestinal tissue. Molecular analysis of the mutations confirmed a remarkable similarity to those found in XEMh1A2 cells (see Table 3), viz., mainly G:C to T:A transversions with a significant number of -1 G:C base pair deletions (Lynch et al., 1997). Nearest neighbor analysis of PhIP-induced hprt mutants in XEMh1A2 cells and in the lacZ transgene showed that in both models there was a preferred motif for mutation, a 5'-GGA-3' sequence. These three characteristics of PhIP-induced mutation, i.e., G:C to T:A transversion, -1 G:C frameshift mutation, and preference for 5'-GGA motifs may constitute a mutational "signature" that is diagnostic of the involvement of PhIP (Gooderham et al., 1997). Whether it is possible to use mutational signatures to assess the involvement of compounds such as PhIP in human disease remains to be established.

Carcinogenicity. All the heterocyclic amines examined thus far have been shown to be carcinogenic in bioassays (Ohgaki et al., 1991). Both MeIQx and PhIP are carcinogenic in both mice and rats (Kato et al., 1988; Esumi et al., 1989; Ito et al., 1991). In the mouse, MeIQx induces liver and lung tumors, lymphomas, and leukemias, whereas in the rat it causes tumors in the liver, the skin, the zymbal gland, and the clitoral gland (Kato et al., 1988). In the mouse, PhIP induces predominantly lymphoma (Esumi et al., 1989), but interestingly in the rat it induces tumors of the colon and the prostate in the male and the colon and breast in the female (Ito et al., 1991), the sites of the most common diet-related cancers found in humans in the Western world. Molecular analysis of the colon tumors induced in male rats given PhIP showed that 5 of 8 had a mutation in the Apc gene (Kakiuchi et al., 1995); in every case the mutation was a -1 G:C base pair frameshift in a 5'-GGGA sequence. Interestingly, mutation of Apc is a very common and early event in human colonic cancer (Powell et al., 1992). Thus, the molecular nature of the mutations detected in these PhIP-induced tumors was identical to the PhIP mutational signature in cultured cells and transgenic mice.



    Conclusions
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References

There is now no doubt that humans who regularly consume cooked meat are exposed to heterocyclic amines on a daily basis. These compounds are readily absorbed and bioavailable and are extensively, but variably, metabolized to derivatives that include the proximal genotoxic N-hydroxylamine compounds. Further metabolism of the HAs generates conjugated metabolites that include glucuronides and sulfate and acetyl esters, the esters being reactive derivatives capable of damaging DNA by forming adducts predominantly with guanine bases. The consequence of this reaction with guanine is a characteristic pattern of mutation. In the case of PhIP, the reproducibility of the nature and sequence context of these mutations are such that they form a mutational signature that is diagnostic of its involvement. Such mutational signatures may be a means of detecting the involvement of heterocyclic amines in mutating critical gene targets such as cancer-associated genes.

The significance of these processes to the etiology of human cancer requires further investigation. Within a population, exposure to the heterocyclic amines will vary depending upon cooking practices and preferences, the level of cooked meat consumption, and the degree of affluence. The genotoxic potential of ingested HAs will depend upon the balance between metabolic activation and detoxication, and the involvement of polymorphic enzymes in some of these reactions would be expected to influence susceptibility to the genotoxic outcome. Subsequently, the site and extent of DNA damage incurred will depend upon the efficiency of DNA repair mechanisms and the genetic predisposition of the individual to accommodating or adapting to the genetic damage. In line with these observations, in a study of acetylation phenotype, meat intake, and risk for adenoma/colon cancer, it was reported that fast acetylators have a higher odds ratio than slow acetylators and that the odds ratio increases to >3 in fast acetylators who have a high meat consumption (Roberts-Thomson et al., 1996). In a separate study, Lang et al. (1994) reported that the combination of rapid acetylation, rapid CYP1A2 activity, and consumption of well done meat markedly increased the risk of colon cancer (odds ratio, >6). Thus, the significance to humans of exposure to the heterocyclic amines is likely to depend upon what combination of these factors pertain to a particular individual, and by estimating the relative contribution of each factor, we may be able to obtain better estimates of overall risk.

    Footnotes

These studies were supported by grants awarded by the Ministry of Agriculture, Fisheries and Food, the Cancer Research Campaign, and the World Cancer Research Fund.

Send reprint requests to: Nigel J. Gooderham, Molecular Toxicology, Imperial College School of Medicine, Sir Alexander Fleming Building, South Kensington Campus, London SW7 2AZ, UK. E-mail: N.gooderham{at}ic.ac.uk

    Abbreviations

Abbreviations used are: HA, heterocyclic amines; MeIQx, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline; DiMeIQx, 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; SULT, sulfotransferase.


    References
Top
Abstract
Introduction
Human Exposure to the...
Metabolism of the Heterocyclic...
Genotoxicity
Conclusions
References


0090-9556/01/2904-529-534$3.00
DMD, 29:529-534, 2001
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Agudo, M. Peluso, N. Sala, G. Capella, A. Munnia, S. Piro, F. Marin, R. Ibanez, P. Amiano, M.J. Tormo, et al.
Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort
Carcinogenesis, June 1, 2009; 30(6): 968 - 976.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. D. Louis, W. Zheng, L. Applegate, L. Shi, and P. Factor-Litvak
Blood harmane concentrations and dietary protein consumption in essential tremor
Neurology, August 9, 2005; 65(3): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Sachse, G. Smith, M. J.V. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, and C.R. Wolf
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Carcinogenesis, November 1, 2002; 23(11): 1839 - 1850.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition